Article · 9 Feb 2026
Conference abstractPublished 11 Jul 2016
COPD: The Indian scenario
Prince Aly Khan Hospital, India Mumbai University, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A global healthcare survey of WHO highlighted some health concerns for India viz., vulnerability of young children, poor sanitation and limited insurance with only 3-5% of Indians covered under health insurance. Th ere is a high percentage of ageing population as well. Chronic diseases like COPD add to this pre-existing burden on healthcare systems. Th e current COPD burden is limited but is expected to increase as the population ages. Th ere is a lot of variation in COPD prevalence in India in rural and urban population. In India, cigarette smoking is just one of the major risk factors for COPD. Exposure to tobacco smoke from hookahs, chillums and bidees, burning of biomass fuel like animal dung and wood, burning of mosquito coils, also poses a great risk. Th is is coupled with under-diagnosis of COPD with Spirometry still being underutilized. Comorbid conditions like ischemic heart disease, hypertension, skeletal muscle dysfunction, osteoporosis, depression, diabetes and renal conditions add to the morbidity. Th e Indian guidelines for COPD classify severity simply as mild, moderate and severe whereas GOLD guidelines have a combined assessment of COPD in the form of a grid which is classifi ed as mild, moderate, severe and very severe. Management options include SABAs/SAMAs, LAMAs and LABAs, inhaled corticosteroids, antibiotics and the preferred device being MDI with spacer or nebulization. Due to diversity of COPD stages at which patients present themselves along with urban and rural prevalence, it will be interesting to ponder over diff erent treatment algorithms based on some case studies.
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pulmonary & Respiratory Medicine.
Commentary · 29 Dec 2025
Evolving IPF: Personalized Therapies, Future Directions
Brief report · 29 Dec 2025
PH/PAH: Advancements, Guidelines, Future Directions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPulmonary & Respiratory Medicine
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Sulaiman Ladhani”
